$131.42
Price
$8.5B
Market Cap
—
P/E Ratio
-207.7
Forward P/E
$-1.81
EPS (TTM)
—
Dividend Yield
$548M
Cash
$10M
Total Debt
64M
Shares Out
$50.48
$141.10
52-Week Range
Institutional Ownership of PROTAGONIST THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for PROTAGONIST THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +27.0% | 20.3K | $1M | $56.21 | |
| 2025-Q2 | |||||
| BUY | NEW | 16.0K | $884265 | $45.85 | |
Insider Trading for PROTAGONIST THERAPEUTICS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.